THIOREDOXIN SYSTEM INHIBITORS ARE EFFECTIVE AGAINST B CELL ACUTE LYMPHOBLASTIC LEUKEMIA IN VITRO AND IN VIVO
EHA Library, Klaudyna Fidyt, 265951
FREQUENCY AND PROGNOSTIC IMPACT OF ZEB2 H1038/Q1072 MUTATIONS IN CHILDHOOD B-OTHER ACUTE LYMPHOBLASTIC LEUKEMIA
EHA Library, Marketa Zaliova, 265952
NATION-WIDE PROSPECTIVE, REAL-TIME MONITORING OF PEGYLATED E.COLI AND ERWINIA ASPARAGINASE THERAPY IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA AND NON-HODGKIN LYMPHOMA IN BELGIUM
EHA Library, Veerle Mondelaers, 265967
DEFINITION OF REPRESENTATIVE BONE MARROW SAMPLE BASED ON PARALLEL EVALUATION OF PERIPHERAL BLOOD DURING THE THERAPY OF ACUTE LYMPHOBLASTIC LEUKEMIA
EHA Library, Barbora Vakrmanova, 265968
NO BLASTS AT DAY 8 IS BETTER THAN MORE IN CORTICO-SENSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA OF CHILDREN
EHA Library, Ines Turki, 265983
EVALUATION OF TELOMERE LENGTH AND TELOMERASE ACTIVITY AS PROGNOSTIC MARKERS IN A PEDIATRIC PATIENT COHORT WITH ACUTE LYMPHOBLASTIC LEUKEMIA
EHA Library, Monika Haubitz, 265984
INTEGRATIVE FUNCTIONAL ANALYSIS OF THE DEK-NUP214 FUSION PROTEIN IN ACUTE MYELOID LEUKAEMIA
EHA Library, Fabio Liberante, 265999
CLINICAL ASPECTS AND DIFFERENTIAL SPLICING IN ACUTE MYELOID LEUKEMIA PATIENTS WITH SRSF2, U2AF1 AND SF3B1 MUTATIONS
EHA Library, Stefanos Bamopoulos, 266000
AZACITIDINE (AZA) ENHANCES ANTILEUKEMIC ACTIVITY OF THE MDM2 INHIBITOR MILADEMETAN IN TP53 WILD-TYPE ACUTE MYELOID LEUKEMIA (AML)
EHA Library, Shingo Noguchi, 266015
AUTOMATIC SEPARATION OF ABERRANT CELL CLUSTERS IN STANDARDIZED FLOW CYTOMETRY EXPERIMENTS PROVIDES A HIGHLY REPRODUCIBLE STRATEGY FOR MONITORING MINIMAL RESIDUAL DISEASE IN ACUTE MYELOBLASTIC LEUKEMIA
EHA Library, Vanesa Diaz, 266016
LONG NON-CODING RNA MANTIS INHIBITS THE PROLIFERATION OF ACUTE MYELOID LEUKEMIA CELL LINE VIA NOTCH SIGNALING PATHWAY
EHA Library, Hongtao Wang, 266033
AN MLL-AF9 ZEBRAFISH LEUKEMIA MODEL
EHA Library, Maryam Saberi, 266035
THE COMBINATION OF BEMCENTINIB, A NOVEL, ORAL, SELECTIVE AXL-INHIBITOR AND LOW-DOSE CYTARABINE YIELDS DURABLE RESPONSES IN AML PATIENTS UNFIT FOR INTENSIVE CHEMOTHERAPY
EHA Library, Sonja Loges, 266059
PROGNOSTIC AND PREDICTIVE IMPACT OF NPM1/FLT3-ITD GENOTYPES AS DEFINED BY 2017 EUROPEAN LEUKEMIANET RISK CATEGORIZATION FROM AML PATIENTS TREATED WITHIN THE INTERNATIONAL RATIFY STUDY
EHA Library, Konstanze Döhner, 266060
NAT10 UPREGULATION INDICATES A POOR PROGNOSIS IN ACUTE MYELOID LEUKEMIA
EHA Library, Rong Hu, 266075
QUALITY OF LIFE EVALUATION IN LONG TERM SURVIVORS WITH ACUTE MYELOID LEUKEMIA: A SINGLE CENTER EXPERIENCE
EHA Library, Francesco Tarantini, 266076
A PHASE 1B/2 CLINICAL STUDY OF TARGETED IDH1 INHIBITION WITH IVOSIDENIB, IN COMBINATION WITH THE BCL-2 INHIBITOR VENETOCLAX, FOR PATIENTS WITH IDH1-MUTATED (MIDH1) MYELOID MALIGNANCIES.
EHA Library, Courtney DiNardo, 266091
LOW-DOSE CYTARABINE WITH OR WITHOUT GLASDEGIB IN NEWLY DIAGNOSED PATIENTS WITH ACUTE MYELOID LEUKEMIA: LONG-TERM ANALYSIS OF A PHASE 2 RANDOMIZED TRIAL
EHA Library, Cristina Papayannidis, 266092
POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDER IN LIVER AND KIDNEY TRANSPLANT RECIPIENTS OVER 33 YEARS: A SINGLE-CENTRE EXPERIENCE
EHA Library, Marta Lopes, 266107
PROGNOSTIC FACTORS AND IMMUNOHISTOCHEMICAL PROFILE IN PRIMARY REFRACTORY AND RECURRENT DIFFUSE LARGE B-CELL LYMPHOMAS
EHA Library, Henrik Lampikoski, 266108
DOUBLE-HIT DIFFUSE LARGE B-CELL LYMPHOMA IN TAIWAN IS PREDOMINANTLY BCL6-REARRANGED AND OVEREXPRESSION OF MYC AND BCL6 IS NOT A GOOD SURROGATE FOR SCREENING
EHA Library, T-Y Chao, 266123
RITUXIMAB DOSE ASSOCIATED WITH OVERALL SURVIVAL IN DIFFUSE LARGE B CELL LYMPHOMA
EHA Library, JEE HYUN KONG, 266124
BIOLOGICAL AND CLINICAL FACTORS THAT FAVOR THE USE OF A SPECIFIC TPO-RA IN ITP PATIENTS. RESULTS FROM A SPANISH MULTICENTER STUDY
EHA Library, Maria Lozano, 266139
PATIENTS WITH HIGHER BODY MASS INDEX TREATED WITH DIRECT / NON VITAMIN K DEPENDENT ANTICOAGULANTS (DOAC / NOAC) EXPERIENCE WORSE CLINICAL OUTCOMES
EHA Library, Marko Lucijanic, 266140
INTEGRATION OF GENOMIC AND EPIGENOMIC DATA REFINES THE REGULATORY MECHANISMS AND BIOLOGICAL SIGNIFICANCE OF CHRONIC LYMPHOCYTIC LEUKEMIA RISK LOCI
EHA Library, Renée Beekman, 266155
CHRONIC LYMPHOCYTIC LEUKEMIA INDUCES SKEWING OF (ANTIGEN-SPECIFIC) T CELL RESPONSES TOWARDS A DYSFUNCTIONAL SHORT-LIVED EFFECTOR PHENOTYPE
EHA Library, Anne Martens, 266156
DNA METHYLTRANSFERASES GENE EXPRESSION LEVELS IN CHRONIC LYMPHOCYTIC LEUKEMIA - IMPACT IN DEVELOPMENT, DIAGNOSIS AND PROGNOSIS
EHA Library, Ana Bela Sarmento-Ribeiro, 266171
INHIBITION OF BROMODOMAIN AND EXTRA-TERMINAL (BET) PROTEINS INCREASES SENSITIVITY TO VENETOCLAX IN CHRONIC LYMPHOCYTIC LEUKEMIA.
EHA Library, Giovanna carrà, 266172
HYPERTENSION IN PATIENTS TREATED WITH IBRUTINIB FOR CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)
EHA Library, Lindsey Roeker, 266186
FRENCH IBRUTINIB OBSERVATIONAL STUDY (FIRE): REAL-WORLD STUDY OF IBRUTINIB TREATMENT FOR CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) IN FRANCE
EHA Library, Caroline Dartigeas, 266187
HAT-PCR IS MORE SENSITIVE THAN FLOW FOR QUANTIFYING MRD IN CHRONIC LYMPHOCYTIC LEUKEMIA
EHA Library, Alexander Morley, 266188
PECULIARITIES OF THE EXPRESSION OF KI-67 AND CD34 HEMOPOIETIC PRECURSOR CELLS IN PB AND BM OF CML PATIENTS WITH THE DIFFERENT RESPONSES TO IMATINIB AND NILOTINIB THERAPY
EHA Library, Tetiana Perekhrestenko, 266202
NEGATIVE MR4.0 CHRONIC MYELOID LEUKEMIA AND ITS IMPLICATIONS FOR TREATMENT-FREE REMISSION
EHA Library, Nuno Cerveira, 266203
TUMOR-DERIVED EXOSOMES MAY BE USED AS NEW INFORMATIVE TOOL FOR THE DETECTION OF BONE MARROW RESIDUAL CML LEUKEMIC CELLS ACTIVITY
EHA Library, Simona Bernardi, 266204
TREATMENT-FREE REMISSION IN REAL-WORLD CHRONIC MYELOID LEUKEMIA PATIENTS: INSIGHTS FROM GERMAN CLINICAL HEMATOLOGY PRACTICES
EHA Library, Alexander Kiani, 266218
ANALYSIS OF THE INFLUENCE OF AGE ON MAJOR MOLECULAR RESPONSE,DEEP MOLECULAR RESPONSE AND SURVIVAL OUTCOMES IN CHRONIC MYELOID LEUKEMIA (CML) PATIENTS TREATED WITH TYROSINE KINASE INHIBITORS (TKIS).
EHA Library, Luis Felipe Casado Montero, 266219
RESULTS OF A PROSPECTIVE MULTICENTER STUDY ON PRO-ATHEROTHROMBOTIC EFFECT INDUCED BY TYROSINE-KINASE INHIBITORS FOR FIRST-LINE TREATMENT OF CML PTS (KIARO TRIAL)
EHA Library, Anna Sicuranza, 266220
GLUCOPHOSPHATE ISOMERASE DEFICIENCY IDENTIFIED BY NEXT-GENERATION SEQUENCING
EHA Library, Sona Vora, 266234
A FLEXIBLE THERAPEUTIC STRATEGY FOR LEUKEMIA USING EX-VIVO EXPANDED T CELLS COMBINED WITH BISPECIFIC ANTIBODIES
EHA Library, Josee Golay, 266235
GMP MANUFACTURING OF ALLOGENEIC CD19 CHIMERIC ANTIGEN RECEPTOR (CAR) CYTOKINE INDUCED KILLER (CIK) CELLS WITH SLEEPING BEAUTY (SB) TRANSPOSON FOR ADOPTIVE IMMUNOTHERAPY
EHA Library, Giuseppe Gaipa, 266236
HIGH PLOIDY LARGE CYTOPLASMIC MEGAKARYOCYTES: KEY NEGATIVE REGULATORS OF HEMATOPOIETIC STEM CELLS AND ESSENTIAL FOR PLATELET PRODUCTION
EHA Library, Susie Nilsson, 266250
GLUCOCORTICOID INDUCED LEUCINE ZIPPER (GILZ) IS REQUIRED FOR HEMATOPOIETIC STEM CELL FUNCTION
EHA Library, Oxana Bereshchenko, 266251
RUNX1 EXPRESSION IN NG2+ PERIVASCULAR CELLS IS REQUIRED FOR PROPER AORTIC EMBRYONIC HAEMATOPOIETIC ACTIVITY IN VIVO
EHA Library, Zaniah Gonzalez Galofre, 266252
POTENTIAL COMBINATIONAL THERAPY OF LEUKEMIC STEM CELLS USING BONE MORPHOGENETIC PROTEIN AND TYROSINE KINASE INHIBITORS.
EHA Library, Caroline Busch, 266266
NEW MOLECULES INSPIRED ON MICROBIOTA METABOLITES TARGETING ACUTE MYELOID LEUKEMIA CELLS
EHA Library, Sergio Algar, 266267
PRIMARY THERAPY AND RELATIVE SURVIVAL IN CLASSIC HODGKIN LYMPHOMA: A NATIONWIDE POPULATION-BASED STUDY AMONG 9,367 ADULT PATIENTS DIAGNOSED IN THE NETHERLANDS FROM 1989 TO 2016
EHA Library, Julia Driessen, 266268
CLINICAL EFFICACY OF THE RIBVD REGIMEN FOR REFRACTORY/RELAPSED (R/R) MANTLE CELL LYMPHOMA (MCL) PATIENTS: A RETROSPECTIVE STUDY OF THE LYSA GROUP.
EHA Library, Caroline Regny, 266282
EFFICACY WAS IMPROVED WITH LENALIDOMIDE/RITUXIMAB (R2) VS RITUXIMAB/PLACEBO IN PATIENTS WITH FOLLICULAR LYMPHOMA IRRESPECTIVE OF POD24 STATUS IN THE PHASE III AUGMENT STUDY
EHA Library, John Leonard, 266283
MARKERS ASSOCIATED WITH SHORT SURVIVAL IN PATIENTS WITH WALDENSTRÖM MACROGLOBULINEMIA
EHA Library, Gordon Ruan, 266284
A PHASE 2, RANDOMIZED, CONTROLLED, OPEN-LABEL TRIAL OF DAILY VERSUS ALTERNATE DAY ORAL IRON IN TREATMENT OF IRON DEFICIENCY ANEMIA
EHA Library, Deepesh Lad, 266298
COMPLIANCE AND CLINICAL BENEFIT OF DEFERASIROX GRANULE FORMULATION VS DISPERSIBLE TABLETS IN PEDIATRIC PATIENTS WITH TRANSFUSIONAL IRON OVERLOAD: RESULTS FROM THE PHASE II CALYPSO STUDY
EHA Library, Ali Taher, 266299
A NEW FTL GENE MUTATION RESPONSIBLE FOR HYPOFERRITINEMIA WITHOUT IRON DEFICIENCY
EHA Library, Patricia Aguilar-Martinez, 266300
LOSS OF 18Q22.1-Q23 IS SIGNIFICANTLY ASSOCIATED WITH GCB-DLBCL AND FAILURE TO ACHIEVE EFS24
EHA Library, Kerstin Wenzl, 266314
A PHASE I STUDY OF THE BTK INHIBITOR ABIVERTINIB (AC0010) IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL LYMPHOMA
EHA Library, Min Yang, 266315
ESTROGEN BETA RECEPTOR: A NEW TARGET FOR DIFFUSE LARGE B-CELL LYMPHOMA.
EHA Library, Myra Langendonk, 266316
INTEGRATED PROFILING OF DNA METHYLATION AND MUTATIONS IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES.
EHA Library, Suguru Morimoto, 266332
MUTATIONS ON COHESIN COMPLEX ARE ASSOCIATED TO A POOR PROGNOSIS IN LOW-RISK MYELODYSPLASTIC SYNDROMES PATIENTS
EHA Library, Marta Martín Izquierdo, 266333
COPY NUMBER VARIATIONS AND UNIPARENTAL DISOMY PREDICT POOR SURVIVAL IN PATIENTS WITH IDIOPATHIC CYTOPENIA OF UNDETERMINED SIGNIFICANCE AND ARE ASSOCIATED WITH MACROCYTOSIS
EHA Library, Stine Mikkelsen, 266334
PROGNOSTIC MUTATIONS IN PATIENTS WITH MYELODYSPLASTIC SYNDROME TREATED WITH HEMATOPOIETIC STEM-CELL TRANSPLANTATION
EHA Library, Zixian Liu, 266348
AUTOIMMUNE AND INFLAMMATORY DISEASES ASSOCIATE TO R-IPSS SCORE BUT NOT TO OVERALL SURVIVAL OR LEUKEMIC EVOLUTION IN MYELODYSPLASTIC SYNDROMES
EHA Library, Thomas Brunet, 266349
AZACITIDINE (VIDAZA®) IN PEDIATRIC PATIENTS WITH RELAPSED ADVANCED MDS: RESULTS OF A PHASE I/II STUDY BY THE ITCC CONSORTIUM AND THE EWOG-MDS GROUP: STUDY ITCC-015
EHA Library, Natasha van Eijkelenburg, 266350
MM-BMSCS INDUCE IMMUNOSENESCENT NAÏVE CD4+ T-CELLS THROUGH THE NOVEL INTERCELLULAR COMMUNICATION - TUNNELING NANOTUBES
EHA Library, Yadan Wang, 266364
INCREASE OF MITOCHONDRIAL ACTIVITY CONTRIBUTES TO RELAPSE IN MULTIPLE MYELOMA, A NOVEL THERAPEUTIC OPPORTUNITY
EHA Library, Alejandra Ortiz, 266365
CHROMATIN ACTIVATION AS A UNIFYING PRINCIPLE UNDERLYING PATHOGENIC MECHANISMS IN MULTIPLE MYELOMA
EHA Library, Raquel Ordoñez, 266366
PARTICIPATION OF IMMUNE RESPONSE GENES POLYMORPHISM IN THE OCCURRENCE OF SOLID TUMORS IN PATIENTS WITH MULTIPLE MYELOMA
EHA Library, Elena Nazarova, 266381
COMPREHENSIVE ANALYSIS OF THE COMPLEXITY AND HETEROGENEITY OF THE LNCRNAS TRANSCRIPTOME IN MULTIPLE MYELOMA
EHA Library, Arantxa Carrasco, 266382
C-MYC-DRIVEN AND PRMT5-DEPENDENT REGULATION OF MULTIPLE MYELOMA CELL PROLIFERATION THROUGH SMCHD1 GENE
EHA Library, Xu peipei, 266383
STEM CELL YIELD AND TRANSPLANTATION IN TRANSPLANT-ELIGIBLE NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS RECEIVING DARATUMUMAB + BORTEZOMIB/THALIDOMIDE/DEXAMETHASONE (D-VTD): PHASE 3 CASSIOPEIA STUDY
EHA Library, Cyrille Hulin, 266397
EFFICACY OF BORTEZOMIB, THALIDOMIDE AND DEXAMETHASONE FOR TREATMENT OF PATIENTS WITH CARFILZOMIB-REFRACTORY MYELOMA IN THE UK NCRI CARDAMON TRIAL
EHA Library, Elizabeth PHILLIPS, 266398
IGH TRANSLOCATIONS WITH UNDEFINED PARTNERS ARE ASSOCIATED WITH SUPERIOR OUTCOME IN MULTIPLE MYELOMA PATIENTS
EHA Library, Xue-Han Mao, 266399
PATIENT-REPORTED OUTCOMES FROM THE INNOVATE™ STUDY: RESULTS OF IBRUTINIB-RITUXIMAB IN WALDENSTRÖM MACROGLOBULINEMIA (WM)
EHA Library, Alessandra Tedeschi, 266413
IMPACT OF PATIENTS CHARACTERISTICS ON HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA: RESULTS FROM THE CHARISMMA STUDY
EHA Library, Laura Rosiñol, 266414
REAL-WORLD USE OF THE TRIPLET REGIMEN CARFILZOMIB, LENALIDOMIDE AND DEXAMETHASONE (KRD) IN PATIENTS WITH RELAPSED MULTIPLE MYELOMA: A SUB-GROUP INTERIM ANALYSIS FROM A PROSPECTIVE OBSERVATIONAL STUDY
EHA Library, Xavier Leleu, 266415
HEALTH-RELATED QUALITY OF LIFE WITH POMALIDOMIDE + LOW-DOSE DEXAMETHASONE + DARATUMUMAB IN PATIENTS WITH RELAPSED REFRACTORY MULTIPLE MYELOMA AFTER LENALIDOMIDE TREATMENT
EHA Library, Donna Reece, 266430
EARLY SALVAGE TREATMENT WITH SECOND-GENERATION NOVEL AGENTS AT BIOCHEMICAL RELAPSE PROLONGS OVERALL SURVIVAL: A REAL-WORLD SINGLE CENTER EXPERIENCE
EHA Library, Francesco Di Raimondo, 266431
PROGNOSTIC VALUE OF KIDNEY BIOPSY INTERSTITIAL FIBROSIS IN REVERSIBILITY OF DIALYSIS-DEPENDENT ACUTE KIDNEY INJURY DUE TO MYELOMA CAST NEPHROPATHY
EHA Library, Evgeniya Kazarina, 266432
THE PROGNOSTIC IMPACT OF PATHOLOGIC FRACTURE AS MYELOMA-DEFINING EVENT IN NEWLY DIAGNOSED MULTIPLE MYELOMA
EHA Library, Rafael Ríos-Tamayo, 266446
TREATMENT PATTERNS FOR MULTIPLE MYELOMA PATIENTS: A RETROSPECTIVE COHORT STUDY IN U.S. ELECTRONIC MEDICAL RECORDS DATABASE 2012-2018
EHA Library, Parameswaran Hari, 266447
ALPINA: REAL WORLD ANALYSIS OF 1ST LINE RVD TREATMENT IN TRANSPLANT ELIGIBLE AND TRANSPLANT-NON-ELIGIBLE MM PATIENTS WITH A FOCUS ON TOLERABILITY AND EFFICACY
EHA Library, Wolfgang Willenbacher, 266448
TRANSCRIPTION ALTERATION OF DNA REPAIR GENES IN PHILADELPHIA CHROMOSOME NEGATIVE MYELOPROLIFERATIVE NEOPLASMS
EHA Library, Martin KIRSCHNER, 266462
46/1 HAPLOTYPE IS ASSOCIATED WITH A HIGHER MONOCYTE/LYMPHOCYTE RATIO IN HEALTHY INDIVIDUALS
EHA Library, Gonzalo Carreno-Tarragona, 266463
SERUM FERRITIN LEVELS ARE INCREASED IN IDIOPATHIC ERYTHROCYTOSIS BUT REDUCED IN POLYCYTHEMIA VERA
EHA Library, Giacomo Biagetti, 266464
REAL-WORLD SAFETY DATA FROM A NONINTERVENTIONAL LONG-TERM POSTAUTHORIZATION SAFETY STUDY OF RUXOLITINIB IN MYELOFIBROSIS
EHA Library, Fiorenza BARRACO, 266478
MAJOR OR CLINICALLY RELEVANT NON-MAJOR HEMORRHAGIC EVENTS IN A LARGE POPULATION OF PATIENTS WITH POLYCYTHEMIA VERA OR ESSENTIAL THROMBOCYTHEMIA: LOCALIZATION, CONSEQUENCES AND DRUG USE
EHA Library, Christophe Nicol, 266479
ELTROMBOPAG AS SECOND LINE THERAPY IN ADULT PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA (ITP) IN ATTEMPT TO TREATMENT-FREE REMISSION. UPDATED RESULTS OF A PHASE II PROSPECTIVE STUDY BY GIMEMA GROUP
EHA Library, Elisa Lucchini, 266494
SAFETY AND EFFICACY OF SELF-ADMINISTERED ROMIPLOSTIM IN PATIENTS WITH IMMUNE THROMBOCYTOPENIA (ITP): RESULTS OF AN INTEGRATED ANALYSIS OF FIVE CLINICAL TRIALS
EHA Library, Dominik Selleslag, 266495
DIFFERENCES IN PERCEPTIONS ON TREATMENT APPROACHES BETWEEN PHYSICIANS AND ITP PATIENTS: RESULTS FROM THE ITP WORLD IMPACT SURVEY (I-WISH)
EHA Library, Alexandra Kruse, 266510
PHYSICIANS’ PERCEPTIONS ON CAUSES OF PRIMARY AND SECONDARY ITP AND LEADING CAUSES OF MISDIAGNOSIS: RESULTS FROM THE ITP WORLD IMPACT SURVEY (I-WISH)
EHA Library, J Bussel, 266511
DOES QUALITY OF LIFE IN MULTIPLE MYELOMA PATIENTS DIFFER BETWEEN NATIONALITIES? A EUROPEAN MULTINATIONAL STUDY
EHA Library, Annemieke van Dongen - Leunis, 266526
COMPARISON OF ALLOPURINOL AND FEBUXOSTAT FOR PREVENTION OF HYPERURICEMIA AND TUMOR LYSIS SYNDROME IN ACUTE LEUKEMIAS
EHA Library, Sumeet Mirgh, 266527
PENICILLIN PROPHYLAXIS AND PNEUMOCOCCAL VACCINE USE IN ADULT SICKLE CELL PATIENTS: A RETROSPECTIVE ANALYSIS OF CLINICAL PRACTICE AND OUTCOMES IN OXFORD, UK
EHA Library, Ayesha Ejaz, 266542
SPECTRUM OF PARVOVIRUS B19 INFECTION IN CHILDREN WITH SICKLE CELL DISEASE: ATYPICAL PRESENTATIONS.
EHA Library, Mohamed ELSHINAWY, 266543
DYSBIOSIS IN GUT MICROBIOTA AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION CAN BE DETERMINED BY THE COMBINATION OF CONDITIONING REGIMEN AND ANTIBIOTIC USAGE
EHA Library, Yasuyuki Arai, 266559
REDUCED INTENSITY CONDITIONING REGIMEN WITH ALEMTUZUMAB BASED T CELL DEPLETION ENABLES EARLY POST-TRANSPLANTATION CELLULAR INTERVENTION RESTORING GRAFT VERSUS LEUKEMIA EFFECTS IN OLDER AML PATIENTS.
EHA Library, Eva Koster, 266560
HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION USING REDUCED-INTENSITY CONDITIONING FOR PEDIATRIC PATIENTS WITH FAMILIAL HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS
EHA Library, Chenguang Jia, 266575
IMMUNOLOGICAL RECONSTITUTION AS A BASIS FOR THE EARLY INITIATION OF PNEUMOCOCCAL VACCINATION AFTER AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION
EHA Library, Igor Iskrov, 266576
IDENTIFICATION OF REFERENCE GENES IN HUMAN TUMORS FOR TUMOR EDUCATED PLATELETS (TEPS) STUDY BASED ON RNA-SEQ DATA
EHA Library, Huaichao Luo, 266591
FUNCTIONAL ACTIVITY OF PLATELETS IN THE APPLICATION OF OLIGOPEPTIDES CONTAINING РROLINE AND ARGININE
EHA Library, Marina Grigorjeva, 266592
ARE NATIONAL GUIDELINES AND MANDATORY TRAINING ENOUGH TO ENSURE SAFE TRANSFUSION PRACTICE?
EHA Library, Silvia Lovato, 266608
ABO INCOMPATIBLE KIDNEY TRANSPLANTATION - ONE CENTRE EXPERIENCE
EHA Library, Marco Sampaio, 266609

Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.


Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.



Google Analytics is used for user behavior tracking/reporting. Google Analytics works in parallel and independently from MLG’s features. Google Analytics relies on cookies and these cookies can be used by Google to track users across different platforms/services.


Save Settings